NK-104, a potent new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, enhances posttranslational catabolism of apolipoprotein B-100 and inhibits secretion of apolipoprotein B-100 and triacylglycerols from HepG2 cells-Reference-Cited by-同舟云学术

NK-104, a potent new 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, enhances posttranslational catabolism of apolipoprotein B-100 and inhibits secretion of apolipoprotein B-100 and triacylglycerols from HepG2 cells

Published:1999-08 Issue:8 Volume:60 Page:423-434
ISSN:0011-393X
Container-title:Current Therapeutic Research
language:en
Short-container-title:Current Therapeutic Research

Author:

Yanagita Teruyoshi,Hara Emi,Yotsumoto Hiroaki,Rahman Shaikh M.,Han Seo-Y.,Cha Jae-Young,Yamamoto Kyosuke

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference39 articles.

1. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?;Stamler;JAMA,1986

2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S);Lancet,1994

3. Prevention of coronary heart disease with prava-statin in men with hypercholesterolemia;Shepherd;N Engl J Med,1995

4. NK-104 a newly developed HMG-CoA reductase inhibitor suppresses neointimal thickening by inhibiting smooth muscle cell growth and fibronectin production in balloon-injured rabbit carotid artery;Kitahara;Jpn J Pharmacol,1998

5. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase;Aoki;Arzneim-Forsch Drug Res,1997

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolocumab Effects on Lipoproteins, Measured by High-Performance Liquid Chromatography;Journal of Atherosclerosis and Thrombosis;2020-11-01

2. Are All Statins the Same?;American Journal Cardiovascular Drugs;2011-04

3. Pitavastatin: a New 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor for the treatment of hyperlipidemia;Advances in Therapy;2010-12-09

4. Pitavastatin: efficacy and safety in intensive lipid lowering;Expert Opinion on Pharmacotherapy;2007-10

5. Pitavastatin: Efficacy and Safety Profiles of A Novel Synthetic HMG-CoA Reductase Inhibitor;Cardiovascular Drug Reviews;2006-06-07